{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:30:54Z","timestamp":1793377854945,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:00Z","timestamp":1746316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["PRE_2022_2_0164"],"award-info":[{"award-number":["PRE_2022_2_0164"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["RTI2018\\u2013098672-B-I00"],"award-info":[{"award-number":["RTI2018\\u2013098672-B-I00"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003451","name":"Euskal Herriko Unibertsitatea","doi-asserted-by":"publisher","award":["PIF21\/61"],"award-info":[{"award-number":["PIF21\/61"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003451","name":"Euskal Herriko Unibertsitatea","doi-asserted-by":"publisher","award":["PIFG23\/45"],"award-info":[{"award-number":["PIFG23\/45"]}],"id":[{"id":"10.13039\/501100003451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejps.2025.107118","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T17:54:20Z","timestamp":1746381260000},"page":"107118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Asialofetuin-Coupled Lipid-Based nanosystems to target the Asialoglycoprotein receptor: Delivering genes to hepatocytes for the treatment of Fabry disease"],"prefix":"10.1016","volume":"210","author":[{"given":"Julen","family":"Rodr\u00edguez-Castej\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Fern\u00e1ndez-Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Beraza-Millor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Solin\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Rodr\u00edguez-Gasc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2478-0884","authenticated-orcid":false,"given":"Ana","family":"del Pozo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107118_bib0001","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI9711","article-title":"Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation","volume":"105","author":"Abe","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2025.107118_bib0002","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jconrel.2023.01.063","article-title":"In vitro-in vivo correlation in nanocarriers: from protein corona to therapeutic implications","volume":"354","author":"Agnihotri","year":"2023","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejps.2025.107118_bib0003","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3390\/molecules28041711","article-title":"Design, physical characterizations, and biocompatibility of cationic solid lipid nanoparticles in HCT-116 and 16-HBE cells: a preliminary study","volume":"28","author":"Alamri","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2025.107118_bib0004","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1208\/s12248-009-9143-y","article-title":"Nonviral gene delivery: principle, limitations, and recent progress","volume":"11","author":"Al-Dosari","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.ejps.2025.107118_bib0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biomaterials.2016.03.004","article-title":"Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles","volume":"90","author":"Apaolaza","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2025.107118_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.gt.3301840","article-title":"Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes","volume":"10","author":"Arangoa","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.ejps.2025.107118_bib0007","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3390\/pharmaceutics15071936","article-title":"Novel golden lipid nanoparticles with small interference ribonucleic acid for substrate reduction therapy in Fabry Disease","volume":"15","author":"Beraza-Millor","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107118_bib0008","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.addr.2020.06.017","article-title":"Lipid-based nanoparticle technologies for liver targeting","volume":"154\u2013155","author":"B\u00f6ttger","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107118_bib0009","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1089\/hum.2012.140","article-title":"Gene therapy approaches for lysosomal storage disease: next-generation treatment","volume":"23","author":"Byrne","year":"2012","journal-title":"Hum. Gene Ther"},{"key":"10.1016\/j.ejps.2025.107118_bib0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s001090000185","article-title":"Asialofetuin liposome-mediated human \u03b11-antitrypsin gene transfer in vivo results in stationary long-term gene expression","volume":"79","author":"Das\u00ed","year":"2001","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejps.2025.107118_bib0011","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2009.10.020","article-title":"Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration","volume":"385","author":"del Pozo-Rodr\u00edguez","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107118_bib0012","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2008.09.004","article-title":"A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors","volume":"133","author":"del Pozo-Rodr\u00edguez","year":"2009","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejps.2025.107118_bib0013","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejpb.2016.10.016","article-title":"Applications of lipid nanoparticles in gene therapy","volume":"109","author":"del Pozo-Rodr\u00edguez","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107118_bib0014","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijpharm.2011.12.052","article-title":"Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice","volume":"425","author":"Delgado","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107118_bib0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ejps.2025.107118_bib0016","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymgme.2021.07.006","article-title":"Gene therapy for Fabry disease: progress, challenges, and outlooks on gene-editing","volume":"134","author":"Domm","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ejps.2025.107118_bib0017","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications","volume":"203","author":"D\u2019Souza","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2025.107118_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00971","article-title":"Non-viral delivery of nucleic acids: insight into mechanisms of overcoming intracellular barriers","volume":"9","author":"Durymanov","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107118_bib0019","doi-asserted-by":"crossref","first-page":"151","DOI":"10.15171\/apb.2015.022","article-title":"Solid lipid nanoparticles as efficient drug and gene delivery systems: recent breakthroughs","volume":"5","author":"Ezzati Nazhad Dolatabadi","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ejps.2025.107118_bib0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.ircmb.2022.04.010","article-title":"mRNA delivery technologies: toward clinical translation","volume":"372","author":"G\u00f3mez-Aguado","year":"2022","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.ejps.2025.107118_bib0021","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/pharmaceutics13091472","article-title":"\u00c1. mRNA-based nanomedicinal products to address corneal inflammation by interleukin-10 supplementation","volume":"13","author":"G\u00f3mez-Aguado","year":"2021","journal-title":"Pharmaceutics"},{"issue":"24","key":"10.1016\/j.ejps.2025.107118_bib0022","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.3390\/molecules25245995","article-title":"Nucleic acid delivery by solid lipid nanoparticles containing switchable lipids: plasmid DNA vs. Messenger RNA","volume":"25","author":"G\u00f3mez-Aguado","year":"2020","journal-title":"Molecules (Basel)"},{"key":"10.1016\/j.ejps.2025.107118_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.102871","article-title":"Lipid-core nanoparticles: classification, preparation methods, routes of administration and recent advances in cancer treatment","volume":"314","author":"Grav\u00e1n","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ejps.2025.107118_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ejps.2025.107118_bib0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3892\/ijmm.2014.1770","article-title":"Co-delivery of plasmid DNA and doxorubicin by solid lipid nanoparticles for lung cancer therapy","volume":"34","author":"Han","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejps.2025.107118_bib0026","article-title":"Effect of the amount of cationic lipid used to complex siRNA on the cytotoxicity and proinflammatory activity of siRNA-solid lipid nanoparticles","volume":"6","author":"Hanafy","year":"2023","journal-title":"Int. J. Pharm. X."},{"issue":"11","key":"10.1016\/j.ejps.2025.107118_bib0027","doi-asserted-by":"crossref","first-page":"eaax0217","DOI":"10.1126\/sciadv.aax0217","article-title":"Durable multitransgene expression in vivo using systemic, nonviral DNA delivery","volume":"5","author":"Handumrongkul","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejps.2025.107118_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304263","article-title":"Multivalent targeting of the asialoglycoprotein receptor by virus-like particles","volume":"19","author":"Hincapie","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.ejps.2025.107118_bib0029","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3390\/ijms24054548","article-title":"Enzyme replacement therapy for FABRY disease: possible strategies to improve its efficacy","volume":"24","author":"Iacobucci","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107118_bib0030","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1021\/mp400467x","article-title":"Overcoming nonviral gene delivery barriers: perspective and future","volume":"10","author":"Jones","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2025.107118_bib0031","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0378-5173(88)90162-7","article-title":"Specific uptake of asialofetuin-labeled liposomes by isolated hepatocytes","volume":"42","author":"Kara","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107118_bib0032","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/mt.2009.220","article-title":"The pharmacological chaperone 1-deoxygalactonojirimycin reduces tissue globotriaosylceramide levels in a mouse model of Fabry Disease","volume":"18","author":"Khanna","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2025.107118_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom11020271","article-title":"Fabry disease: molecular basis, pathophysiology, diagnostics and potential therapeutic directions","volume":"11","author":"Kok","year":"2021","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.ejps.2025.107118_bib0034","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","article-title":"Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA","volume":"13","author":"Kulkarni","year":"2017","journal-title":"Nanomedicine: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ejps.2025.107118_bib0035","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1021\/jacs.0c09029","article-title":"Chemo-physical strategies to advance the in vivo functionality of targeted nanomedicine: the next generation","volume":"143","author":"Li","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.ejps.2025.107118_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124924","article-title":"STAT3 Decoy oligodeoxynucleotides-loaded solid lipid nanoparticles induce cell death and inhibit invasion in ovarian cancer cells","volume":"10","author":"Ma","year":"2015","journal-title":"PloS one"},{"key":"10.1016\/j.ejps.2025.107118_bib0037","first-page":"46","article-title":"Systemic gene delivery using lipid envelope systems and its potential in overcoming challenges","author":"Malaviya","year":"2021","journal-title":"Int. J. Pharm. Drug Anal."},{"key":"10.1016\/j.ejps.2025.107118_bib70","doi-asserted-by":"crossref","first-page":"114238","DOI":"10.1016\/j.ejpb.2024.114238","article-title":"Development of cationic solid lipid nanoparticles incorporating cholesteryl-9-carboxynonanoate (9CCN) for delivery of antagomiRs to macrophages","volume":"197","author":"Mall\u00e9n","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107118_bib0038","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40265-019-01090-4","article-title":"A review in Fabry disease","volume":"79","author":"McCafferty","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2025.107118_bib0039","unstructured":"Mehta A., Hughes D.A. Fabry disease. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, eds. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle; August 5, 2002."},{"issue":"3","key":"10.1016\/j.ejps.2025.107118_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103505","article-title":"Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids","volume":"28","author":"Mendon\u00e7a","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2025.107118_bib0041","article-title":"Fabrication of active targeting lipid nanoparticles: challenges and perspectives","volume":"16","author":"Menon","year":"2022","journal-title":"Mater. Today Adv."},{"key":"10.1016\/j.ejps.2025.107118_bib0042","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/js970367a","article-title":"Analysis of plasmid DNA from a pharmaceutical perspective","volume":"87","author":"Middaugh","year":"1998","journal-title":"J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.ejps.2025.107118_bib0043","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307809121","article-title":"Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies","volume":"121","author":"Nabar","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2025.107118_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108592","article-title":"Understanding the influence of experimental factors on bio-interactions of nanoparticles: towards improving correlation between in vitro and in vivo studies","volume":"694","author":"Natarajan","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejps.2025.107118_bib0045","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1021\/acs.biomac.3c00194","article-title":"Exploring receptor binding affinities and hepatic cell association of N-acetyl-d-galactosamine-modified \u03b2-cyclodextrin-based polyrotaxanes for liver-targeted therapies","volume":"24","author":"Ohashi","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejps.2025.107118_bib0046","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"\u03b1-galactosidase A deficient mice: a model of fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejps.2025.107118_bib0047","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jconrel.2006.08.009","article-title":"Influence of plasmid DNA topology on the transfection properties of DOTAP\/DOPE lipoplexes","volume":"115","author":"Remaut","year":"2006","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejps.2025.107118_bib0048","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/pharmaceutics13060771","article-title":"Rodr\u00edguez-Gasc\u00f3n, A. \u03b1-galactosidase A augmentation by non-viral gene therapy: evaluation in Fabry disease mice","volume":"13","author":"Rodr\u00edguez-Castej\u00f3n","year":"2021","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.ejps.2025.107118_bib0049","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s13346-024-01583-0","article-title":"Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review","volume":"14","author":"Rodr\u00edguez-Castej\u00f3n","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2025.107118_bib0050","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3390\/nano12142339","article-title":"Galactomannan-decorated lipidic nanocarrier for gene supplementation therapy in Fabry disease","volume":"12","author":"Rodr\u00edguez-Castej\u00f3n","year":"2022","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.ejps.2025.107118_bib0051","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1166\/jbn.2015.1968","article-title":"Solid lipid nanoparticles as non-viral vectors for gene transfection in a cell model of Fabry Disease","volume":"11","author":"Ruiz de Garibay","year":"2015","journal-title":"J. Biomed. Nanotech."},{"key":"10.1016\/j.ejps.2025.107118_bib0052","first-page":"3","article-title":"Barriers to liposomal gene delivery: from application site to the target","volume":"15","author":"Saffari","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107118_bib0053","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1093\/nar\/gkm445","article-title":"Regulation of DNA nucleases by molecular crowding","volume":"35","author":"Sasaki","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ejps.2025.107118_bib0054","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng. Transl. Med."},{"issue":"2","key":"10.1016\/j.ejps.2025.107118_bib0055","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jconrel.2011.11.014","article-title":"Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers","volume":"161","author":"Scholz","year":"2012","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejps.2025.107118_bib0056","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1089\/hum.1997.8.13-1585","article-title":"Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration","volume":"8","author":"Song","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejps.2025.107118_bib0057","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/acs.bioconjchem.3c00546","article-title":"GalNAc- or Mannose-PEG-functionalized polyplexes enable effective lectin-mediated DNA delivery","volume":"35","author":"Steffens","year":"2024","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.ejps.2025.107118_bib0058","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1208\/s12249-022-02294-w","article-title":"Optimization of DOTAP\/chol cationic lipid nanoparticles for mRNA, pDNA, and oligonucleotide delivery","volume":"23","author":"Sun","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2025.107118_bib0059","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11095-022-03460-2","article-title":"Structure and function of cationic and ionizable lipids for nucleic acid delivery","volume":"40","author":"Sun","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107118_bib0060","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.2147\/IJN.S158884","article-title":"Cholesteryl oleate-loaded cationic solid lipid nanoparticles as carriers for efficient gene-silencing therapy","volume":"13","author":"Su\u00f1\u00e9-Pou","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.ejps.2025.107118_bib0061","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/nano9040631","article-title":"MMP-9 downregulation with lipid nanoparticles for inhibiting corneal neovascularization by gene silencing","volume":"9","author":"Torrecilla","year":"2019","journal-title":"Nanomaterials (Basel)"},{"issue":"4","key":"10.1016\/j.ejps.2025.107118_bib0062","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/genes16040376","article-title":"The bright future of mRNA as a therapeutic molecule","volume":"16","author":"V\u00e9lez","year":"2025","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ejps.2025.107118_bib0063","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2217\/nnm-2018-0112","article-title":"Gene delivery in the cornea: in vitro & ex vivo evaluation of solid lipid nanoparticle-based vectors","volume":"13","author":"Vicente-Pascual","year":"2018","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.ejps.2025.107118_bib0064","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/pharmaceutics12060584","article-title":"Topical administration of SLN-based gene therapy for the treatment of corneal inflammation by De Novo IL-10 production","volume":"12","author":"Vicente-Pascual","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107118_bib0065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12951-023-02044-5","article-title":"Emerging non-viral vectors for gene delivery","volume":"21","author":"Wang","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ejps.2025.107118_bib0066","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1021\/nn301922x","article-title":"In vitro - In vivo translation of lipid nanoparticles for hepatocellular siRNA delivery","volume":"6","author":"Whitehead","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2025.107118_bib0067","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jprot.2016.01.016","article-title":"In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes","volume":"136","author":"Wi\u015bniewski","year":"2016","journal-title":"J. Proteomics"},{"key":"10.1016\/j.ejps.2025.107118_bib0068","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.omtm.2020.07.002","article-title":"AAV2\/6 Gene therapy in a Murine model of Fabry Disease results in supraphysiological enzyme activity and effective substrate reduction","volume":"18","author":"Yasuda","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.ejps.2025.107118_bib0069","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-022-31993-y","article-title":"Multi-step screening of DNA\/lipid nanoparticles and co-delivery with siRNA to enhance and prolong gene expression","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725001174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:22:13Z","timestamp":1762330933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725001174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":70,"alternative-id":["S0928098725001174"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107118","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asialofetuin-Coupled Lipid-Based nanosystems to target the Asialoglycoprotein receptor: Delivering genes to hepatocytes for the treatment of Fabry disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107118"}}